-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
December 29, 2015 - Hyperuricemia is believed to be the most important risk factor for developing gout. … IL-17A is a cytokine
believed to be involved in developing delayed-type hypersensitivity reactions … IL-17A is a cytokine believed to be involved in developing delayed-type hypersensitivity
reactions. … IL-17 is a cytokine purportedly involved in developing delayed-type
hypersensitivity reactions. … (Wilmington, DE), is developing baricitinib for
treating patients with RA who are either naïve to existing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
February 01, 2012 - Since developing their prototype, the manufacturer has
marketed two tests, PreGen Plus (2003-2008) and … Since developing their prototype, (further
developed and offered as a LDT [PreGen Plus] by LabCorp 2003 … Since developing their prototype, the manufacturer has
marketed two tests, PreGen Plus (2003-2008) and … Since developing their prototype, (further
developed and offered as a LDT [PreGen Plus] by LabCorp 2003 … Suggest removing the phrase in parens and developing
the thought more fully in a following sentence
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/future-research-prioritization-methods_research.pdf
January 01, 2013 - literature on topics assigned to them by AHRQ and conduct additional analyses when
appropriate prior to developing … preliminary criteria and a model worksheet that
EPCs and stakeholders could use when identifying, developing … these high-priority research needs, the
EPC will consider the feasibility and capacity criteria when developing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-blueprint_research.pdf
June 01, 2010 - BLUEPRINT FOR A FUTURE DISTRIBUTED RESEARCH NETWORK
The DEcIDE (Developing Evidence to Inform … This report is based on research conducted by the DEcIDE (Developing Evidence to Inform
Decisions about … including research (e.g., comparing medicines for a specific condition)
and data infrastructure (e.g., developing
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Risk factors for developing gout include obesity,
hypertension, alcohol consumption, diuretic use, … Allopurinol-Refractory Gout
Key Facts: Hyperuricemia is believed to be the most important risk factor for developing … Allopurinol-Refractory Gout
Intervention: Hyperuricemia is thought to be the most important risk factor for developing
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-249-malnutrition-hospitalized-adults-evidence-summary.pdf
October 01, 2021 - that the Agency for Healthcare Research and
Quality (AHRQ) convene a panel of experts charged with developing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-health-equity-preventive-services-comments.pdf
December 03, 2019 - impact the ability of
members of these populations to quit smoking and thereby
reduce their risk of developing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-249-malnutrition-hospitalized-adults-evidence-summary_0.pdf
October 01, 2021 - that the Agency for Healthcare Research and
Quality (AHRQ) convene a panel of experts charged with developing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
August 01, 2012 - care decisions of primary
care physicians and to provide background to material to
assist groups developing … that non-caucasian
groups, particularly African-Americans and Latinos, have an
elevated risk for developing … The risk of developing
CKD and ESRD in these groups is likely not explained
entirely by the higher … hypertension in these populations.African-Americans, for
example, are at disproportionate risk for developing … The risk of developing CKD and
ESRD in these groups is likely not explained entirely by the
higher
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-classification_research.pdf
December 01, 2010 - Work Plan for Methods Research on
Methods Research Report
Developing and Testing a Tool for … Developing and Testing a Tool for the Classification of Study Designs in Systematic
Reviews of Interventions … Top Ranked Classification Tools
ES-1
Developing and Testing a Tool for the Classification … Two members of the Steering Committee (LH, KB) who were
not involved in developing the reference standard … We consider the results of this study as a
contribution to the developing evidence base that may help
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-disposition-comments.pdf
January 01, 2022 - published
definitions for long COVID,
limitations in current
definitions, and
considerations for developing … published
definitions for long COVID,
limitations in current
definitions, and
considerations for developing … published
definitions for long COVID,
limitations in current
definitions, and
considerations for developing … Developing a Model
System of Rehabilitation Care for Patients Post-COVID-19. … The report described
definitions of long COVID and
considerations for developing
a new definition.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
November 01, 2014 - Some patients may require intubation
after developing severe HAP; in these cases, clinicians
should … antibiotic stewardship
programs to employ to improve antibiotic use.37 In fact, the
IDSA guidelines for developing … counts of culture, and development of antibiotic
resistance can also yield information useful for developing … Diseases
Society of America and the Society for Healthcare Epidemiology
of America guidelines for developing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
March 13, 2012 - presents at a much later stage than
other common cancers.1 This in turn has led to intense interest in developing … of OC use (e.g., dose/formulation, age at initiation, duration of use) affect
the relative risk of developing … history of breast and ovarian cancer, BRCA1/BRCA2 mutation status, parity) affect the
relative risk of developing … In developing this comprehensive overview, we will apply the rules of evidence and
formulation of strength
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
May 01, 2008 - May 2008
Research from the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Network … The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of … This report is based on research conducted by the University of Maryland at Baltimore
DEcIDE (Developing … Report
to AHRQ DEcIDE (Developing Evidence to
Inform Decisions and Effectiveness) Network.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-drugs-utilization_research.pdf
January 25, 2011 - Division,
University of Pennsylvania School of Medicine,
Philadelphia, PA
2 University of Pennsylvania Developing … Department of Health
and Human Services, as part of the Developing Evi-
dence to Inform Decisions about
-
effectivehealthcare.ahrq.gov/products/bereaved-persons/protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/han.pdf
December 26, 2012 - risk estimates: NCI CCRAT
Two
bars
illustrating
integrated
textual and
visual risk for developing
-
effectivehealthcare.ahrq.gov/sites/default/files/investing_elwyn_presentation.pdf
January 01, 2009 - www.effectivehealthcare.ahrq.gov/index.cfm)
Slide
1:
Investing
in
deliberation:
defining
and
developing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research-appendix-c.xlsx
May 31, 2025 - ratification of potential alternatives
4) Implementation - Accelerate response: Build technology by developing
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data-repository-reviews-charter-140305.pdf
June 01, 2012 - community to increase visibility, recommending
technical enhancements to further develop SRDR, and developing